These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24326249)

  • 1. Galectin-3 interactions with glycosphingolipids.
    Collins PM; Bum-Erdene K; Yu X; Blanchard H
    J Mol Biol; 2014 Apr; 426(7):1439-51. PubMed ID: 24326249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based rationale for differential recognition of lacto- and neolacto- series glycosphingolipids by the N-terminal domain of human galectin-8.
    Bohari MH; Yu X; Zick Y; Blanchard H
    Sci Rep; 2016 Dec; 6():39556. PubMed ID: 28000747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigens.
    Bum-Erdene K; Leffler H; Nilsson UJ; Blanchard H
    FEBS J; 2015 Sep; 282(17):3348-67. PubMed ID: 26077389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity.
    Ideo H; Seko A; Ishizuka I; Yamashita K
    Glycobiology; 2003 Oct; 13(10):713-23. PubMed ID: 12851289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
    Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
    Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structure of a protease-resistant mutant form of human galectin-8 with two carbohydrate recognition domains.
    Yoshida H; Yamashita S; Teraoka M; Itoh A; Nakakita S; Nishi N; Kamitori S
    FEBS J; 2012 Oct; 279(20):3937-51. PubMed ID: 22913484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
    Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
    Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological effects, biosynthesis, and derivatization of key human milk tetrasaccharides, lacto-
    Zhu Y; Luo G; Wan L; Meng J; Lee SY; Mu W
    Crit Rev Biotechnol; 2022 Jun; 42(4):578-596. PubMed ID: 34346270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontypeable Haemophilus influenzae-binding gangliosides of human respiratory (HEp-2) cells have a requisite lacto/neolacto core structure.
    Berenson CS; Sayles KB; Huang J; Reinhold VN; Garlipp MA; Yohe HC
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):171-82. PubMed ID: 16051069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected.
    John CM; Jarvis GA; Swanson KV; Leffler H; Cooper MD; Huflejt ME; Griffiss JM
    Cell Microbiol; 2002 Oct; 4(10):649-62. PubMed ID: 12366402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation.
    Wu AM; Singh T; Wu JH; Lensch M; André S; Gabius HJ
    Glycobiology; 2006 Jun; 16(6):524-37. PubMed ID: 16540530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adhesive specificity of the soluble human lectin, IgE-binding protein, toward lipid-linked oligosaccharides. Presence of the blood group A, B, B-like, and H monosaccharides confers a binding activity to tetrasaccharide (lacto-N-tetraose and lacto-N-neotetraose) backbones.
    Feizi T; Solomon JC; Yuen CT; Jeng KC; Frigeri LG; Hsu DK; Liu FT
    Biochemistry; 1994 May; 33(20):6342-9. PubMed ID: 8193150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
    Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
    Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential One-Pot Multienzyme Chemoenzymatic Synthesis of Glycosphingolipid Glycans.
    Yu H; Li Y; Zeng J; Thon V; Nguyen DM; Ly T; Kuang HY; Ngo A; Chen X
    J Org Chem; 2016 Nov; 81(22):10809-10824. PubMed ID: 27736072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taloside inhibitors of galectin-1 and galectin-3.
    Collins PM; Oberg CT; Leffler H; Nilsson UJ; Blanchard H
    Chem Biol Drug Des; 2012 Mar; 79(3):339-46. PubMed ID: 22136701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical constitution of gangliosides of the vertebrate nervous system.
    Wiegandt H
    Behav Brain Res; 1995 Jan; 66(1-2):85-97. PubMed ID: 7755905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between DMBT1 and galectin 3 is modulated by the structure of the oligosaccharides carried by DMBT1.
    Rossez Y; Coddeville B; Elass E; Quinchon JF; Vidal O; Corfield AP; Gosset P; Lacroix JM; Michalski JC; Robbe-Masselot C
    Biochimie; 2011 Mar; 93(3):593-603. PubMed ID: 21167898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria of the human intestinal microbiota produce glycosidases specific for lacto-series glycosphingolipids.
    Falk P; Hoskins LC; Larson G
    J Biochem; 1990 Sep; 108(3):466-74. PubMed ID: 2277039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Engineering of
    Liao Y; Wu J; Li Z; Wang J; Yuan L; Lao C; Chen X; Yao J
    J Agric Food Chem; 2023 Aug; 71(30):11555-11566. PubMed ID: 37467490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.